Universal bispecific antibody for targeting tumor cells for destruction by cytotoxic T cells.

Previous studies have demonstrated that bispecific hybrid antibodies produced by cell-cell fusion or chemically conjugated heteroaggregates can direct cytotoxic T lymphocytes to kill target cells for which they have no intrinsic specificity, a phenomenon we call effector cell retargeting (ECR). Thes...

ver descrição completa

Detalhes bibliográficos
Main Authors: Gilliland, L, Clark, MR, Waldmann, H
Formato: Journal article
Idioma:English
Publicado em: 1988